Back to company

Pharmaforce ApS: Financial statements 2025

CVR: 26394198

Pharmaforce ApS (CVR 26394198) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. That is a decrease of 3.7% compared with the year before. Equity amounted to DKK 4,328,882. The solvency ratio was 65.9%. The company had 4 employees in the financial year.

Gross Profit
5,238,511 kr.
Profit/Loss
914,232 kr.
Equity
4,328,882 kr.
Total Assets
6,573,345 kr.
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-5.2 mio.914 t.4.3 mio.4
2024-5.4 mio.1.5 mio.3.9 mio.4
2023-3.7 mio.262 t.2.9 mio.5
2022-3.6 mio.283 t.2.9 mio.5
2021-4.2 mio.367 t.2.9 mio.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Pharmaforce ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

Pharmaforce ApS: The 2024 annual report is outMay 8, 2025

Pharmaforce ApS has published its annual report for 2024. Gross profit came to DKK 5,437,134, and the net result was DKK 1,494,355.

About Pharmaforce ApS

Pharmaforce ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Mads Louie Frazier. The company is owned by Pfam Holding ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. Equity amounted to DKK 4,328,882.